resveratrol has been researched along with tamoxifen in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 10 (35.71) | 29.6817 |
| 2010's | 15 (53.57) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Armstrong, MD; Arteaga, CL; Brown, HA; Buck, JR; Cho, HP; Criswell, TL; Lindsley, CW; Scott, SA; Selvy, PE; Thomas, AL | 1 |
| Albert, S; Csuk, R; Schwarz, S; Siewert, B | 1 |
| Gallardo-Godoy, A; Gever, JR; Ghaemmaghami, S; Irwin, JJ; Jacobson, MP; Li, Z; Prusiner, SB; Rao, S; Renslo, AR; Silber, BM; Widjaja, K | 1 |
| Dong, C; Hu, Z; Huang, J; Ning, W; Tang, C; Yang, L; Zhang, S; Zhou, HB | 1 |
| Ikeda, K; Kawai, Y; Mizutani, K; Yamori, Y | 1 |
| Baumgartner, G; Hamilton, G; Hejna, M; Hoffmann, O; Mallinger, R; Raderer, M; Ulsperger, E | 1 |
| Aiello, FB; Brunetti, M; Caltagirone, S; Natali, PG; Piantelli, M; Poggi, A; Ranelletti, FO; Rossi, C | 1 |
| Beck, V; Eder, R; Jungbauer, A; Klinge, CM; Risinger, KE; Watts, MB | 1 |
| Welsh, J; Wietzke, JA | 1 |
| Alkhalaf, M; El-Mowafy, AM | 1 |
| Hock, B; Li, W; Seifert, M; Xu, Y | 1 |
| Bhatnagar, S; Blankenship, KA; Brey, DM; Keynton, RS; Klinge, CM; Noisin, EL; Risinger, KE; Sumanasekera, WK; Zhao, L | 1 |
| Anderson, LM | 1 |
| Basaran, A; Cosan, DT; Degirmenci, I; Gunes, HV; Sahin, FM; Soyocak, A | 1 |
| Klinge, CM; Mattingly, KA | 1 |
| Bennington, JL; Dairkee, SH; Luciani-Torres, G; Meng, Z; Moore, DH; Sayeed, A | 1 |
| Feng, J; Li, Y; Ma, HZ; Miao, S; Shi, XP; Wen, AD; Wu, Y; Xin, HL; Zhang, W; Zhang, XF | 1 |
| Biswas, PK; Chakraborty, S; Levenson, AS | 1 |
| Cadena-Nava, RD; Cornelissen, JJ; Koay, MS; Palomares, LA; Ruiz-Garcia, J; Sánchez-Sánchez, L; Vazquez-Duhalt, R | 1 |
| Chen, Y; Guo, SW; Liu, X; Zhang, H; Zhu, B | 1 |
| Kala, R; Tollefsbol, TO | 1 |
| Bhat, HK; Bhat, NK; Chatterjee, A; Padhye, S; Ronghe, A | 1 |
| Chang, JC; Chiou, RY; Lin, WS; Weng, BB | 1 |
| Bagde, A; Chowdhury, N; Kutlehria, S; Patel, K; Singh, M; Vhora, I | 1 |
| Chan, L; Cummer, R; DeGagne, G; Krishnan, S; Lieben Louis, X; Meikle, S; Meikle, Z; Netticadan, T; Wigle, JT; Yu, L | 1 |
| Casao, A; Cebrián-Pérez, JA; Gimeno-Martos, S; Muiño-Blanco, T; Pérez-Pé, R; Santorromán-Nuez, M | 1 |
2 review(s) available for resveratrol and tamoxifen
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Cancer biology and hormesis: comments on Calabrese (2005).
Topics: Adaptation, Physiological; Antineoplastic Agents; Carcinogens; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; No-Observed-Adverse-Effect Level; Resveratrol; Risk Assessment; Stilbenes; Suramin; Tamoxifen; Tumor Cells, Cultured | 2005 |
26 other study(ies) available for resveratrol and tamoxifen
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Topics: Breast Neoplasms; Drug Design; Enzyme Inhibitors; Humans; Isoenzymes; Neoplasm Invasiveness; Phospholipase D | 2009 |
Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chemistry Techniques, Synthetic; Humans; Mice; NIH 3T3 Cells; Stilbenes | 2012 |
Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.
Topics: Animals; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Mice; Molecular Structure; PrPSc Proteins; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Novel Hybrid Conjugates with Dual Suppression of Estrogenic and Inflammatory Activities Display Significantly Improved Potency against Breast Cancer.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Humans; Inflammation; Ligands; Macrophages; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Molecular Structure; NF-kappa B; Protein Conformation; Resveratrol; Signal Transduction; Structure-Activity Relationship; Sulfones | 2018 |
Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Drug Interactions; Estrogen Antagonists; Estrogens, Non-Steroidal; Isoflavones; Mice; Mitogens; Osteoblasts; Phytoestrogens; Plant Preparations; Procollagen-Proline Dioxygenase; Resveratrol; Stilbenes; Tamoxifen | 1998 |
Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants.
Topics: Alkaline Phosphatase; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Renal Cell; Cell Differentiation; Cell Line; Culture Media, Conditioned; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Kidney Neoplasms; Lung; Male; Osteoblasts; Pancreatic Neoplasms; Phytoestrogens; Plant Preparations; Prostatic Neoplasms; Resveratrol; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 1999 |
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential.
Topics: Animals; Anticarcinogenic Agents; Apigenin; Catechin; Cell Division; Curcumin; Female; Flavonoids; Growth Inhibitors; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Transplantation; Quercetin; Resveratrol; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 2000 |
Estrogenic activity in white and red wine extracts.
Topics: Animals; beta-Galactosidase; Breast Neoplasms; CHO Cells; Cricetinae; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Gene Expression; Genes, Reporter; Humans; Plant Extracts; Receptors, Estrogen; Response Elements; Resveratrol; Saccharomyces cerevisiae; Stilbenes; Tamoxifen; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Vitis; Wine | 2003 |
Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Blotting, Western; Breast Neoplasms; Calcitriol; Cell Cycle; Dose-Response Relationship, Drug; Estrogens, Non-Steroidal; Flow Cytometry; Genes, Reporter; Genistein; Humans; Isoflavones; Phytoestrogens; Plant Preparations; Promoter Regions, Genetic; Protein Binding; Protein Structure, Tertiary; Receptors, Calcitriol; Resveratrol; Stilbenes; Tamoxifen; Time Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Up-Regulation | 2003 |
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Antineoplastic Agents, Phytogenic; Arachidonic Acids; Breast Neoplasms; Cell Division; Cyclic AMP; Cyclic GMP; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; Receptors, Estrogen; Resveratrol; Rolipram; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 2003 |
Comparative study of estrogenic potencies of estradiol, tamoxifen, bisphenol-A and resveratrol with two in vitro bioassays.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Benzhydryl Compounds; Biological Assay; Estradiol; Estrogens, Non-Steroidal; Immunoenzyme Techniques; Phenols; Receptors, Estrogen; Resveratrol; Sensitivity and Specificity; Stilbenes; Tamoxifen; Yeasts | 2004 |
Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Blotting, Western; Cattle; Cell Nucleus; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Epidermal Growth Factor; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Flavonoids; Fulvestrant; Humans; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mice; Microcirculation; Models, Biological; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenols; Phosphorylation; Polyphenols; Resveratrol; Serine; Signal Transduction; Stilbenes; Tamoxifen; Time Factors; Transfection; Umbilical Veins; Wine | 2005 |
Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines.
Topics: Adenocarcinoma; Analysis of Variance; Cell Line, Tumor; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Humans; Quercetin; Resveratrol; Stilbenes; Tamoxifen; Tannins; Telomerase | 2011 |
Diesel exhaust particulate extracts inhibit transcription of nuclear respiratory factor-1 and cell viability in human umbilical vein endothelial cells.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Drug Antagonism; Electron Transport Complex IV; Estradiol; Human Umbilical Vein Endothelial Cells; Humans; Mitochondria; Nuclear Respiratory Factor 1; Particulate Matter; Raloxifene Hydrochloride; Resveratrol; Stilbenes; Tamoxifen; Transcription, Genetic; Vehicle Emissions | 2012 |
Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
Topics: Antigens, CD; Antineoplastic Agents, Hormonal; Apoptosis; Base Sequence; Binding Sites; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Fatty Acid-Binding Proteins; Female; Gene Expression; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Kaplan-Meier Estimate; Molecular Sequence Data; Promoter Regions, Genetic; Proportional Hazards Models; Protein Binding; Resveratrol; Stilbenes; Tamoxifen; Transforming Growth Factor beta | 2013 |
Resveratrol sensitizes tamoxifen in antiestrogen-resistant breast cancer cells with epithelial-mesenchymal transition features.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Estrogen Antagonists; Female; Humans; MCF-7 Cells; Resveratrol; Signal Transduction; Smad Proteins; Stilbenes; Tamoxifen; Transforming Growth Factor beta | 2013 |
Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
Topics: Animals; Binding Sites; Diethylstilbestrol; Dimerization; Estradiol; Estrogen Receptor alpha; Fulvestrant; Humans; Hydrogen Bonding; Ligands; Models, Molecular; Molecular Dynamics Simulation; Phytoestrogens; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Resveratrol; Stilbenes; Tamoxifen | 2013 |
Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450.
Topics: Activation, Metabolic; Antineoplastic Agents; Bacillus megaterium; Bacterial Proteins; Biocatalysis; Bromovirus; Capsid Proteins; Cytochrome P-450 Enzyme System; Drug Carriers; Drug Delivery Systems; Humans; Kinetics; Nanocapsules; Nanoparticles; Prodrugs; Resveratrol; Stilbenes; Tamoxifen; Virion | 2014 |
Resveratrol Reduces Myometrial Infiltration, Uterine Hyperactivity, and Stress Levels and Alleviates Generalized Hyperalgesia in Mice With Induced Adenomyosis.
Topics: Adenomyosis; Animals; Animals, Newborn; Behavior, Animal; Cluster Analysis; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glutamate Decarboxylase; Hyperalgesia; Mice, Inbred ICR; Myometrium; Nucleus Raphe Magnus; Pain Threshold; Phenotype; Reaction Time; Resveratrol; Stilbenes; Tamoxifen; Time Factors; Uterine Contraction; Uterus | 2015 |
A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells.
Topics: Breast Neoplasms; Cell Line, Tumor; DNA Methylation; Epigenesis, Genetic; Estrogen Receptor alpha; Female; Humans; Promoter Regions, Genetic; Resveratrol; Stilbenes; Tamoxifen | 2016 |
Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Catechols; Cell Proliferation; Cells, Cultured; Drug Synergism; Female; Humans; MCF-7 Cells; Resveratrol; Schiff Bases; Stilbenes; Tamoxifen | 2016 |
The phytogestrogenic stilbenes, arachidin-1 and resveratrol, modulate regulatory T cell functions responsible for successful aging in aged ICR mice.
Topics: Age Factors; Aging; Animals; Biomarkers; Cytokines; Dietary Supplements; Female; Immunophenotyping; Lymphocyte Activation; Mice; Mice, Inbred ICR; Phenotype; Resveratrol; Stilbenes; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Tamoxifen | 2016 |
Development of Hot Melt Extruded Solid Dispersion of Tamoxifen Citrate and Resveratrol for Synergistic Effects on Breast Cancer Cells.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Development; Drug Synergism; Hot Temperature; Humans; MCF-7 Cells; Rats; Rats, Sprague-Dawley; Resveratrol; Spectroscopy, Fourier Transform Infrared; Tamoxifen; X-Ray Diffraction | 2018 |
Divergent Effects of Resveratrol on Rat Cardiac Fibroblasts and Cardiomyocytes.
Topics: Animals; Apoptosis; Cell Death; Cell Proliferation; Cell Survival; Cells, Cultured; Estrogen Receptor alpha; Humans; Myocytes, Cardiac; Myofibroblasts; Phytoalexins; Rats; Resveratrol; Sesquiterpenes; Signal Transduction; Stilbenes; Tamoxifen | 2019 |
Involvement of progesterone and estrogen receptors in the ram sperm acrosome reaction.
Topics: Acrosome Reaction; Animals; Antioxidants; Cell Survival; Cells, Cultured; Estradiol; Estrogens; Male; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Resveratrol; Sheep; Sperm Capacitation; Sperm Motility; Spermatozoa; Tamoxifen | 2021 |